The current COVID-19 pandemic has revealed that increased age and the presence of co-existing health conditions, such as cancer, cardiovascular, […]
Since the discovery of the CRISPR-Cas9 system in 2012, the potential of editing genes for improved agricultural output and treatment […]
A recent article published in Nature, describes a breakthrough in our knowledge of the human genome with the first gapless, […]
The promise of single-cell gene expression data Genomic data are an excellent source of novel disease biomarkers and targets. In […]
“Genomics is crowding out ways of reducing inequality” is just one of the overarching messages of the latest report by […]
*** This post was written by Dr. Anja Brunner, science writer (Science Inbound) Interview with Cristina Gamba, Global Product Manager […]
A study from the Murdoch Children’s Research Institute (MCRI) has found a genetic cause for a rare disease that causes […]
CRISPR gene-editing is a technique that allows the genomes of living organisms to be modified. Naturally, this has been looked […]
Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]
The human body has 40 trillion cells and roughly 200 different cell types. Amongst the diverse cell types lies incredible […]
